Gankhuyag Nomundelger, Yu Kyeong Nam, Davaadamdin Orkhonselenge, Lee Somin, Cho Won Young, Park Changhoon, Jiang Hu-Lin, Singh Bijay, Chae Chan-Hee, Cho Myung-Haing, Cho Chong-Su
1 Laboratory of Toxicology, BK21 PLUS Program for Creative Veterinary Science Research and The Research Institute of Veterinary Science, College of Veterinary Medicine, Seoul National University , Seoul 151-742, Republic of Korea.
2 Laboratory of Pathology, College of Veterinary Medicine, Seoul National University , Seoul, Korea.
J Aerosol Med Pulm Drug Deliv. 2017 Apr;30(2):81-90. doi: 10.1089/jamp.2016.1301. Epub 2016 Oct 28.
Rab25, a member of Rab family of small guanosine triphosphatase, is associated with progression of various types of human cancers, including lung cancer, the leading cause of cancer-associated deaths around the globe.
In this study, we report the gene therapeutic effect of short hairpin Rab25 RNA (shRab25) on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced lung tumorigenesis in female A/J mice. Initially, mice (6 weeks old) were injected with single dose of NNK (2 mg/0.1 mL saline/mouse) by intraperitoneal injection to induce the tumor. Eight weeks later, shRab25 was complexed with glycerol propoxylate triacrylate-spermine (GPT-SPE) copolymer and delivered into tobacco-induced lung cancer models through a nose-only inhalation system twice a week for 2 months.
GPT-SPE/shRab25 largely decreased the tobacco-induced tumor numbers and tumor volume in the lungs compared to GPT-SPE- or GPT-SPE/shScr-delivered groups. Remarkably, aerosol-delivered GPT-SPE/shRab25 significantly decreased the expression level of Rab25 and other prominent apoptosis-related proteins in female A/J mice. The apoptosis in these mice was determined by detecting the expression level of Bcl-2, proliferating cell nuclear antigen, Bax, and further confirmed by TUNEL assay.
Our results strongly confirm the tumorigenic role of Rab25 in tobacco carcinogen-induced lung cancer and hence demonstrate aerosol delivery of shRab25 as a therapeutic target for lung cancer treatment.
Rab25是小GTP酶Rab家族的成员,与包括肺癌在内的多种人类癌症的进展相关,肺癌是全球癌症相关死亡的主要原因。
在本研究中,我们报告了短发夹Rab25 RNA(shRab25)对4-(甲基亚硝胺基)-1-(3-吡啶基)-1-丁酮(NNK)诱导的雌性A/J小鼠肺肿瘤发生的基因治疗效果。最初,给6周龄的小鼠腹腔注射单剂量的NNK(2毫克/0.1毫升生理盐水/只小鼠)以诱导肿瘤。8周后,将shRab25与甘油丙氧基三丙烯酸酯-精胺(GPT-SPE)共聚物复合,并通过仅经鼻吸入系统每周两次输送到烟草诱导的肺癌模型中,持续2个月。
与GPT-SPE或GPT-SPE/shScr递送组相比,GPT-SPE/shRab25在很大程度上减少了烟草诱导的肺部肿瘤数量和肿瘤体积。值得注意的是,气溶胶递送的GPT-SPE/shRab25显著降低了雌性A/J小鼠中Rab25和其他突出的凋亡相关蛋白的表达水平。通过检测Bcl-2、增殖细胞核抗原、Bax的表达水平来确定这些小鼠中的细胞凋亡,并通过TUNEL试验进一步证实。
我们的结果有力地证实了Rab25在烟草致癌物诱导的肺癌中的致瘤作用,因此证明气溶胶递送shRab25作为肺癌治疗的治疗靶点。